Article
Effect of liraglutide on expression of inflammatory genes in type 2 diabetes
17 Sept 2021
Abstract excerpt
Anti-inflammatory effects of glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment in T2D may contribute to the cardiovascular benefits observed with GLP-1 RAs in outcome studies. We investigated if the GLP-1 RA liraglutide exerts anti-inflammatory effects through modulation of inflammatory gene expression in peripheral blood mononuclear cells (PBMCs). From 54 participants of a double-blinded trial where...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
